Moderna Presents Phase II Oncology Data
3 stories
June 2
- Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
Seeking Alpha · Jun 2
- Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data - Slideshow
Seeking Alpha · Jun 2
- BioInvent International AB (publ) (BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors Transcript
Seeking Alpha · Jun 2